Readystate Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Readystate Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-199,358	Closed	-$455K	–	860
2024 Q2	$455K	Buy	+199,358	New	+$762K	0.01%	544

Readystate Asset Management's GTHX Position: Q3 2024 in Review

Readystate Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 199,358 shares — an estimated $455K sold.

Readystate Asset Management first reported a position in GTHX in Q2 2024 and held it in 1 quarter. The position peaked at $455K in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Readystate Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Readystate Asset Management sold 199,358 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $455K.
Readystate Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Readystate Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $455K in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Readystate Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.